The RUBRIC (acronym for "Rational Use of Biologics in rare Refractory Immune mediated inflammatory diseases (IMIDs) Consortium") registry collects information on the safety and effectivity of off-label treatment with biologicals in patients with rare, therapy-refractory IMID's in the Netherlands.
View